AAAAAA
Results:
1-24
|
Results: 24
Authors:
ASWANIA OA
CORLETT SA
CHRYSTYN H
Citation: Oa. Aswania et al., VALIDATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR URINARY NEDOCROMIL SODIUM FOLLOWING ORAL AND INHALED ADMINISTRATION, Journal of chromatography B. Biomedical sciences and applications, 718(2), 1998, pp. 290-295
Authors:
HAWKSWORTH GM
CHRYSTYN H
Citation: Gm. Hawksworth et H. Chrystyn, CLINICAL PHARMACY IN PRIMARY-CARE, British journal of clinical pharmacology, 46(5), 1998, pp. 415-420
Authors:
WRIGHT DJ
AYKROYD RG
CHRYSTYN H
Citation: Dj. Wright et al., RATING CLINICAL PHARMACY INTERVENTIONS BY CLINICAL PANELS - WHICH HEALTH-PROFESSIONALS SHOULD BE INCLUDED, British journal of clinical pharmacology, 46(3), 1998, pp. 278-305
Authors:
ASWANIA OA
CORLETT SA
CHRYSTYN H
Citation: Oa. Aswania et al., DETERMINATION OF THE RELATIVE BIOAVAILABILITY OF NEDOCROMIL SODIUM TOTHE LUNG FOLLOWING INHALATION USING URINARY-EXCRETION, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 475-478
Authors:
ASWANIA OA
CORLETT SA
CHRYSTYN H
Citation: Oa. Aswania et al., DEVELOPMENT AND VALIDATION OF AN ION-PAIR LIQUID-CHROMATOGRAPHIC METHOD FOR THE QUANTITATION OF SODIUM CROMOGLYCATE IN URINE FOLLOWING INHALATION, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 373-378
Authors:
CHRYSTYN H
Citation: H. Chrystyn, IS TOTAL PARTICLE DOSE MORE IMPORTANT THAN PARTICLE DISTRIBUTION, Respiratory medicine, 91, 1997, pp. 17-19
Authors:
MCALEER SD
FOONDUN AS
FEELY M
CHRYSTYN H
Citation: Sd. Mcaleer et al., STEADY-STATE CLEARANCE RATES OF WARFARIN AND ITS ENANTIOMERS IN THERAPEUTICALLY DOSED PATIENTS, Chirality, 9(1), 1997, pp. 13-16
Authors:
SMITH L
MCGOWAN L
MOSSBARCLAY C
WHEATER J
KNASS D
CHRYSTYN H
Citation: L. Smith et al., AN INVESTIGATION OF HOSPITAL GENERATED PHARMACEUTICAL CARE WHEN PATIENTS ARE DISCHARGED HOME FROM HOSPITAL, British journal of clinical pharmacology, 44(2), 1997, pp. 163-165
Authors:
ABOSEHMAHALBIDY AZM
YORK P
WONG V
LOSOWSKY MS
CHRYSTYN H
Citation: Azm. Abosehmahalbidy et al., IMPROVED BIOAVAILABILITY AND CLINICAL-RESPONSE IN PATIENTS WITH CHRONIC LIVER-DISEASE FOLLOWING THE ADMINISTRATION OF A SPIRONOLACTONE - BETA-CYCLODEXTRIN COMPLEX, British journal of clinical pharmacology, 44(1), 1997, pp. 35-39
Authors:
HINDLE M
PEERS EM
PARRYBILLINGS M
CHRYSTYN H
Citation: M. Hindle et al., RELATIVE BIOAVAILABILITY OF SALBUTAMOL TO THE LUNG FOLLOWING INHALATION VIA A NOVEL DRY POWDER INHALER AND A STANDARD METERED-DOSE INHALER, British journal of clinical pharmacology, 43(3), 1997, pp. 336-338
Authors:
CHEGE JK
ELARAUD KA
CLARK BJ
CHRYSTYN H
Citation: Jk. Chege et al., OPTIMAL PARTICLE-SIZE FOR AEROSOLS, Thorax, 52(6), 1997, pp. 586-587
Authors:
CHRYSTYN H
Citation: H. Chrystyn, COMMUNITY CARE OF ASTHMA - THE PHARMACIST AS COUNSELOR, Journal of Pharmacy and Pharmacology, 49, 1997, pp. 51-54
Authors:
CORLETT SA
CHRYSTYN H
Citation: Sa. Corlett et H. Chrystyn, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ENANTIOMERS OF CYCLOPHOSPHAMIDE IN SERUM, Journal of chromatography B. Biomedical applications, 682(2), 1996, pp. 337-342
Authors:
CHRYSTYN H
Citation: H. Chrystyn, LUNG BIOAVAILABILITY OF CHLOROFLUOROCARBON FREE, DRY POWDER AND CHLOROFLUOROCARBON CONTAINING FORMULATIONS OF SALBUTAMOL, British journal of clinical pharmacology, 42(2), 1996, pp. 257-257
Authors:
CORLETT SA
PARKER D
CHRYSTYN H
Citation: Sa. Corlett et al., PHARMACOKINETICS OF IFOSFAMIDE AND ITS ENANTIOMERS FOLLOWING A SINGLE1-H INTRAVENOUS-INFUSION OF THE RACEMATE IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA, British journal of clinical pharmacology, 39(4), 1995, pp. 452-455
Authors:
CHEGE JK
CHRYSTYN H
Citation: Jk. Chege et H. Chrystyn, GENERIC SALBUTAMOL METERED-DOSE INHALERS - REPLY, Thorax, 50(5), 1995, pp. 590-591
Authors:
HINDLE M
NEWTON DAG
CHRYSTYN H
Citation: M. Hindle et al., DRY POWDER INHALERS ARE BIOEQUIVALENT TO METERED-DOSE INHALERS - A STUDY USING A NEW URINARY ALBUTEROL (SALBUTAMOL) ASSAY TECHNIQUE, Chest, 107(3), 1995, pp. 629-633
Authors:
CORLETT SA
CHRYSTYN H
Citation: Sa. Corlett et H. Chrystyn, ENANTIOMERIC SEPARATION OF R-IFOSFAMIDE AND S-IFOSFAMIDE AND THEIR DETERMINATION IN SERUM FROM CLINICAL SUBJECTS, Journal of chromatography B. Biomedical applications, 654(1), 1994, pp. 152-158
Authors:
PRASAD VK
CORLETT SA
ABAASI K
HENEY D
LEWIS I
CHRYSTYN H
Citation: Vk. Prasad et al., IFOSFAMIDE ENANTIOMERS - PHARMACOKINETICS IN CHILDREN, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 447-449
Authors:
CHRYSTYN H
Citation: H. Chrystyn, STANDARDS FOR BIOEQUIVALENCE OF INHALED PRODUCTS, Clinical pharmacokinetics, 26(1), 1994, pp. 1-6
Authors:
HINDLE M
CHRYSTYN H
Citation: M. Hindle et H. Chrystyn, RELATIVE BIOAVAILABILITY OF SALBUTAMOL TO THE LUNG FOLLOWING INHALATION USING METERED-DOSE INHALATION METHODS AND SPACER DEVICES, Thorax, 49(6), 1994, pp. 549-553
Authors:
CHEGE JK
CHRYSTYN H
Citation: Jk. Chege et H. Chrystyn, VOLUMATIC USAGE - SOME GENERIC SALBUTAMOL METERED-DOSE INHALERS CAN BE USED, Thorax, 49(11), 1994, pp. 1162-1163
Authors:
CHRYSTYN H
Citation: H. Chrystyn, BIOAVAILABILITY OF SALBUTAMOL - REPLY, Thorax, 49(11), 1994, pp. 1183-1183
Authors:
HINDLE M
NEWTON DAG
CHRYSTYN H
Citation: M. Hindle et al., INVESTIGATIONS OF AN OPTIMAL INHALER TECHNIQUE WITH THE USE OF URINARY SALBUTAMOL EXCRETION AS A MEASURE OF RELATIVE BIOAVAILABILITY TO THELUNG, Thorax, 48(6), 1993, pp. 607-610
Risultati:
1-24
|